Please consider downloading the latest version of Internet Explorer
to experience this site as intended.
Tools Search Main Menu

Tag: cancer

Rochester chemists find new means to ‘block’ cancer cell growth

Rochester chemists find new means to ‘block’ cancer cell growth

October 31, 2017

A pathway that enables embryonic cells to develop into different organs can be reactivated by cancer cells. A cyclic peptide has been found that can block the activation of this pathway, and is also less likely to trigger resistance in cancer cells.

Continue Reading

‘Microbubbles’ boost search for head, neck cancer treatment

‘Microbubbles’ boost search for head, neck cancer treatment

October 25, 2017

A Medical Center team recently received a $3.8 million grant to continue their investigation of an innovative technology that could lead to preventative treatments for radiation damage in patients.

Continue Reading

Rochester positioned among first to offer FDA approved cancer therapy

Rochester positioned among first to offer FDA approved cancer therapy

October 20, 2017

UR Medicine’s Wilmot Cancer Institute will be among the first sites in the world to offer CAR T-cell therapy —a new type of immunotherapy approved this week by the FDA—to adults with aggressive lymphoma. The engineered gene therapy has been described as a revolutionary “living drug” and one of the most powerful cancer treatments to emerge in recent years.

Continue Reading

Protein identified in post-chemo cell death puzzle

Protein identified in post-chemo cell death puzzle

September 11, 2017

Researchers have identified a protein that is required for cell death after undergoing chemotherapy—at least, it appears, in male mice.

Continue Reading

Cancer patients fare much worse after cardiac arrest

Cancer patients fare much worse after cardiac arrest

August 2, 2017

Patients with advanced cancer who suffer cardiac arrest in a hospital have a survival rate of less than 10 percent—half the rate of patients without cancer, according to a nationwide study led by the Medical Center.

Continue Reading

Can the sunshine vitamin help lymphoma patients?

Can the sunshine vitamin help lymphoma patients?

July 19, 2017

A new $3 million grant to the Wilmot Cancer Institute allows oncologists to evaluate whether adding vitamin D to standard therapy will help cancer patients live longer.

Continue Reading

Study points to new way to slow cancer cell growth

Study points to new way to slow cancer cell growth

May 25, 2017

Researchers from the Center for RNA Biology have identified a new way to potentially slow the fast-growing cells that characterize all types of cancer.

Continue Reading

Exercise beats medication in fighting cancer fatigue

Exercise beats medication in fighting cancer fatigue

March 2, 2017

Exercise or psychological therapy work better than medications to reduce cancer-related fatigue and should be recommended first to patients, according to a Wilmot Cancer Institute–led study published in JAMA Oncology.

Continue Reading

Chemo-brain among women with breast cancer is pervasive, study shows

Chemo-brain among women with breast cancer is pervasive, study shows

December 28, 2016

The largest study to date of memory and cognition problems related to chemotherapy shows that women with breast cancer report substantial issues lasting as long as six months after treatment.

Continue Reading

Scientists find new gene tool for predicting course of prostate cancer

Scientists find new gene tool for predicting course of prostate cancer

December 20, 2016

Researchers at the University’s Wilmot Cancer Institute and Roswell Park in Buffalo have discovered a possible new tool for predicting whether prostate cancer will reoccur following surgery based on the expression patterns of four genes.

Continue Reading